LIVZON PHARMA Publishes 2026 Q3 Report, Calls Second EGM and Unveils 2026-2028 Shareholder Return Plan

Bulletin Express
10/23

On 23 October 2026, Hong Kong-listed Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) released a package of corporate documents comprising:

• 2026 Third Quarterly Report • Circular dated 23 October 2026 • Notice and Proxy Form for the 2026 Second Extraordinary General Meeting (EGM) • Profit Distribution Proposal for the Third Quarter of 2026 • Shareholder Return Plan for 2026-2028

All materials are now available in both English and Chinese on the company’s website (www.livzon.com.cn) and on the Hong Kong Stock Exchange website (www.hkexnews.hk).

Shareholders whose holdings are maintained through CCASS and other intermediaries may register an e-mail address with their broker, bank, custodian, or nominee to receive electronic notifications when future corporate communications are published. Those unable to access the online versions can obtain printed copies free of charge by submitting the enclosed request form to Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, or by e-mailing 1513-ecom@vistra.com.

The company secretary, Liu Ning, signed the notification on behalf of the board. For enquiries, shareholders may contact Tricor’s hotline at +852 2980 1333 during business hours, Monday to Friday (excluding public holidays).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10